9:55 AM ยท 21 January 2025

Moderna secures funding to develop bird flu vaccine; shares gain 4.5% ๐Ÿ’‰

Shares of Moderna (MRNA.US), which is best known as a major player in the international vaccine market, gained nearly 4.5% today after it received a government grant to, among other things, accelerate the development of a proprietary vaccine for avian flu.      

The funding package will finance the expansion of clinical trials for up to five additional avian flu subtypes and provide additional support for late-stage development and licensing of prepandemic mRNA-based vaccines. The grant was made before the inauguration of Donald Trump's presidency.   

The company's fundamental situation does not look very good. The company is not generating profits, behind which is an irregular and small revenue structure. Debt is growing, and with it, so is the overall employment level. The company's spending pressure remains very high. The company's shares have lost nearly 66% over the past year. Source: XTB 

The company's shares are trading at the lowest levels seen since 2020. Source: xStation 

30 October 2026, 2:16 PM

US OPEN: Bloody end to the quarter. Intel loses nearly 1/3 of its value, and the crypto market shakes off a hack on the largest exchange.

30 October 2026, 11:08 AM

Market Wrap: Binance Hack Shakes Markets. European Equities Under Pressure

30 October 2026, 9:27 AM

Intel has come face to face with reality. A Turnaround is still a long way off.

29 October 2026, 10:25 PM

Amazon: Record-breaking operating margin outshined by capex growth

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissรฃo de Valores Mobiliรกrios (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits